Historical valuation data is not available at this time.
RELX PLC is a global provider of information-based analytics and decision tools for professional and business customers across industries. The company operates through four segments: Risk & Business Analytics, Legal, Scientific, Technical & Medical (STM), and Exhibitions. RELX holds a strong market position in data analytics and professional publishing, serving sectors such as legal, healthcare, insurance, and scientific research. Its competitive advantages include proprietary datasets, advanced analytics capabilities, and a subscription-based revenue model that ensures recurring income. The company's Elsevier division is a leader in scientific publishing, while LexisNexis dominates legal and risk analytics.
Heavy investment in AI and machine learning for data analytics, ownership of proprietary databases, and continuous expansion of digital offerings
RELX offers stable growth potential through its market-leading positions in analytics and professional information services. The company's high-margin, subscription-based business model provides resilience, though investors should monitor competitive pressures in publishing and data privacy regulations. Long-term growth drivers include increasing digitization and data-driven decision making across industries.
RELX Annual Report 2022, Investor Presentations, Bloomberg Intelligence